MetLife (MET) valuation
MetLife P/E ratio history
MetLife trades at 19.1 times its earnings over the last twelve months and 9.4 times the earnings analysts expect over the next twelve.
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
MetLife valuation against its peers
| Company | Market value | P/E | Forward P/E |
|---|---|---|---|
| MetLifeMET | $64.4B | 19.1 | 9.4 |
| AflacAFL | $63.1B | 13.4 | 16.9 |
| Prudential FinancialPRU | $40.4B | 10.6 | 8.4 |
| Principal Financial GroupPFG | $23.9B | 12.4 | 11.2 |
| Globe LifeGL | $12.4B | 10.6 | 9.9 |
| Peer median | 11.5 | 10.5 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: MET returns
No forecast, no recommendation. This page describes MetLife from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.